TY  - GEN
AU  - Keeping,Sam
AU  - Wu,Elise
AU  - Chan,Keith
AU  - Mojebi,Ali
AU  - Ferrante,Shannon Allen
AU  - Balakumaran,Arun
TI  - Pembrolizumab versus the standard of care for relapsed and refractory classical Hodgkin's lymphoma progressing after brentuximab vedotin: an indirect treatment comparison
SN  - 1747-4094
PY  - 2019///0228
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Brentuximab Vedotin
KW  - Female
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Immunoconjugates
KW  - Male
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
UR  - https://doi.org/10.1080/17474086.2018.1475226
ER  -